N.J. should be more 'pro' about antibody treatments | Letters
N.J. should be more ‘pro’ about antibody treatments | Letters Updated Jan 24, 2021; Facebook Share Hospitals are in danger of reaching capacity if the COVID-19 pandemic worsens. The U.S. Food and Drug Administration has approved monoclonal antibodies as an early and very effective treatment, but far too few Americans and New Jerseyans are receiving this medication or are aware it exists. The most vulnerable who qualify for the medical combination may avoid hospitalization by receiving this treatment. It must be more accessible for everyone. It will save lives. President Joe Biden is fi...